Literature DB >> 6287032

Structure and expression of class II defective herpes simplex virus genomes encoding infected cell polypeptide number 8.

H Locker, N Frenkel, I Halliburton.   

Abstract

Defective genomes present in serially passaged virus stocks derived from the tsLB2 mutant of herpes simplex virus type 1 were found to consist of repeat units in which sequences from the U(L) region, within map coordinates 0.356 and 0.429 of standard herpes simplex virus DNA, were covalently linked to sequences from the end of the S component. The major defective genome species consisted of repeat units which were 4.9 x 10(6) in molecular weight and contained a specific deletion within the U(L) segment. These tsLB2 defective genomes were stable through more than 35 sequential virus passages. The ratios of defective virus genomes to helper virus genomes present in different passages fluctuated in synchrony with the capacity of the passages to interfere with standard virus replication. Cells infected with passages enriched for defective genomes overproduced the infected cell polypeptide number 8, which had previously been mapped within the U(L) sequences present in the tsLB2 defective genomes. In contrast, the synthesis of most other infected cell polypeptides was delayed and reduced. The abundant synthesis of infected cell polypeptide number 8 followed the beta regulatory pattern, as evident from kinetic studies and from experiments in which cycloheximide, canavanine, and phosphonoacetate were used. However, in contrast to many beta (early) and gamma (late) viral polypeptides, the synthesis of infected cell polypeptide number 8 was only minimally reduced when cells infected with serially passaged tsLB2 were incubated at 39 degrees C. The tsLB2 mutation had previously been mapped within the domains of the gene encoding infected cell polypeptide number 4, the function of which was shown to be required for beta and gamma viral gene expression. It is thus possible that the tsLB2 mutation affects the synthesis of only a subset of the beta and gamma viral polypeptides. An additional polypeptide, 74.5 x 10(3) in molecular weight, was abundantly produced in cells infected with a number of tsLB2 passages. This polypeptide was most likely expressed from truncated gene templates within the most abundant, deleted repeats of tsLB2 defective virus DNA.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6287032      PMCID: PMC256161     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  The terminal repetition of herpes simplex virus DNA.

Authors:  R H Grafstrom; J C Alwine; W L Steinhart; C W Hill; R W Hyman
Journal:  Virology       Date:  1975-09       Impact factor: 3.616

2.  Inverted repetitions in the chromosome of herpes simplex virus.

Authors:  P Sheldrick; N Berthelot
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

3.  Anatomy of herpes simplex virus DNA. III. Characterization of defective DNA molecules and biological properties of virus populations containing them.

Authors:  N Frenkel; R J Jacob; R W Honess; G S Hayward; H Locker; B Roizman
Journal:  J Virol       Date:  1975-07       Impact factor: 5.103

4.  Anatomy of herpes simplex virus DNA. II. Size, composition, and arrangement of inverted terminal repetitions.

Authors:  S Wadsworth; R J Jacob; B Roizman
Journal:  J Virol       Date:  1975-06       Impact factor: 5.103

5.  Regulation of herpesvirus macromolecular synthesis: sequential transition of polypeptide synthesis requires functional viral polypeptides.

Authors:  R W Honess; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

6.  Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins.

Authors:  R W Honess; B Roizman
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

7.  Defective virions of herpes simplex viruses.

Authors:  D L Bronson; G R Dreesman; N Biswal; M Benyesh-Melnick
Journal:  Intervirology       Date:  1973       Impact factor: 1.763

Review 8.  Defective interfering viruses.

Authors:  A S Huang
Journal:  Annu Rev Microbiol       Date:  1973       Impact factor: 15.500

9.  Isolation and characterization of a large molecular-weight polypeptide of herpes simplex virus type 1.

Authors:  R J Courtney; M Benyesh-Melnick
Journal:  Virology       Date:  1974-12       Impact factor: 3.616

10.  Mode of inhibition of herpes simplex virus DNA polymerase by phosphonoacetate.

Authors:  J C Mao; E E Robishaw
Journal:  Biochemistry       Date:  1975-12-16       Impact factor: 3.162

View more
  9 in total

Review 1.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

2.  Identification of the lytic origin of DNA replication in human cytomegalovirus by a novel approach utilizing ganciclovir-induced chain termination.

Authors:  F M Hamzeh; P S Lietman; W Gibson; G S Hayward
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

3.  The herpes simplex virus virion host shutoff function.

Authors:  A D Kwong; N Frenkel
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

4.  Herpes simplex virus virion host shutoff function.

Authors:  A D Kwong; J A Kruper; N Frenkel
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

5.  Nucleotide sequence and structural features of a novel US-a junction present in a defective herpes simplex virus genome.

Authors:  E S Mocarski; L P Deiss; N Frenkel
Journal:  J Virol       Date:  1985-07       Impact factor: 5.103

6.  Herpes simplex virus amplicon: effect of size on replication of constructed defective genomes containing eucaryotic DNA sequences.

Authors:  A D Kwong; N Frenkel
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

7.  Mapping of the transcriptional initiation site of the herpes simplex virus type 1 ICP8 gene in infected and transfected cells.

Authors:  L Su; D M Knipe
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

8.  Deletion of the UL4 gene sequence of equine herpesvirus 1 precludes the generation of defective interfering particles.

Authors:  Robert A Charvat; Yunfei Zhang; Dennis J O'Callaghan
Journal:  Virus Genes       Date:  2012-07-03       Impact factor: 2.332

9.  Use of amplicon-6 vectors derived from human herpesvirus 6 for efficient expression of membrane-associated and -secreted proteins in T cells.

Authors:  Ronen Borenstein; Oded Singer; Adi Moseri; Niza Frenkel
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.